GlassScriptPhysician profile
Val H Irion
NPI 1760684732
$7,525.32
in general payments reported to CMS, 2019-2025
22 companies · $1,926 in 2025
The $1,926 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,152 · 2020: $487 · 2021: $2,234 · 2022: $683 · 2023: $464 · 2024: $579 · 2025: $1,926.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,148 · Travel and Lodging: $821.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,148.08 |
| Travel and Lodging | $821.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,217.48 | 2021-2025 | Blueprint Patient Specific Instrumentation, Aequalis Ascend Flex, Mako |
| Midsouth Orthopedics INC. | $1,717.28 | 2019-2023 | |
| Smith+Nephew, INC. | $1,630.80 | 2019-2025 | Na, N/A, Intellio Link Werewolf |
| Pacira Therapeutics, INC. | $762.47 | 2019-2021 | |
| Vericel Corporation | $218.79 | 2019-2024 | Maci |
| Horizon Therapeutics Plc | $189.12 | 2019-2021 | |
| Convatec INC. | $107.59 | 2024-2025 | |
| Curonix LLC | $107.46 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Sanara Medtech INC. | $81.95 | 2021-2023 | Celleraterx |
| Paratek Pharmaceuticals, INC. | $78.97 | 2021-2023 | Nuzyra |
| Ferring Pharmaceuticals INC. | $70.86 | 2020-2025 | Euflexxa |
| Vertex Pharmaceuticals Incorporated | $63.93 | 2025 | |
| Wright Medical Technology, INC. | $43.99 | 2019 | |
| Sanofi-Aventis U.S. LLC | $42.86 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $38.10 | 2023-2025 | Exparel, Zilretta, Iovera |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $31.79 | 2024 | Irrisept |
| Axogen | $24.64 | 2020 | |
| Endo Pharmaceuticals INC. | $23.63 | 2019 | |
| Abbvie INC. | $22.71 | 2021 | |
| Ethicon US, LLC | $22.31 | 2020 | |
| Dynasplint Systems INC. | $15.69 | 2024 | Dynasplint |
| Kowa Pharmaceuticals America, INC. | $12.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Val Irion listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.